Investments in and Advances to Joint Ventures (Tables)

9 Months Ended

Sep. 30, 2019

Equity Method Investments And Joint Ventures [Abstract]

Summary of Financial Information for Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	December 31, 2018		September 30, 2019
Current assets	$	287,227	$	254,204
Noncurrent assets		2,689		2,836
Total assets		289,916		257,040
Current liabilities		199,833		198,079
Total liabilities		199,833		198,079
Total joint venture equity	$	90,083	$	58,961

	Three Months Ended				Nine Months Ended
	September 28, 2018		September 30, 2019		September 28, 2018		September 30, 2019
Revenue	$	126,480	$	117,611	$	413,548	$	341,719
Costs		116,468		108,839		262,146		322,826
Net income	$	10,012	$	8,772	$	151,402	$	18,893
Net income attributable to noncontrolling interests	$	4,844	$	4,481	$	10,316	$	8,012

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	December 31, 2018		September 30, 2019
Current assets	$	707,457	$	778,876
Noncurrent assets		876,385		956,367
Total assets		1,583,842		1,735,243
Current liabilities		560,306		625,949
Noncurrent liabilities		813,269		895,514
Total liabilities		1,373,575		1,521,463
Total joint venture equity		210,267		213,780
Investments in and advances to unconsolidated joint ventures	$	63,560	$	66,584

	Three Months Ended				Nine Months Ended
	September 28, 2018		September 30, 2019		September 28, 2018		September 30, 2019
Revenue	$	482,634	$	474,600	$	1,234,946	$	1,225,284
Costs		462,042		452,001		1,186,184		1,166,008
Net income	$	20,592	$	22,599	$	48,762	$	59,276
Equity in earnings of unconsolidated joint ventures	$	12,707	$	7,274	$	25,577	$	29,305